ACHP Statement on the Announcement of the First Ten Drugs to be Negotiated in the IRA
As the only national payer organization that supported robust drug …
08/29/2023
Securing Affordable Treatments for All Americans
Anticompetitive practices within the pharmaceutical industry, coupled with outdated patent laws that inhibit more affordable biosimilars and generics, have resulted in skyrocketing drug costs for all Americans – but especially seniors and those with chronic conditions. ACHP advocates for sensible policies such as price transparency to rein in sky-high costs so that patients can afford the medications they need.
Recent
ACHP Statement on Senate Finance Committee PBM Markup
ACHP commends Senate Finance Committee Chairman Ron Wyden (D-OR) and …
07/25/2023
ACHP Reaffirms Support for Comprehensive Drug Pricing Reform
ACHP is the only national payer group pushing for comprehensive …
06/08/2023
ACHP Comments on USPTO’s Patent Rights Initiatives
ACHP submitted a comment letter to USPTO with recommendations to …
02/02/2023
Medicare Advantage: The Choice of America’s Seniors
By offering lower costs, more benefits and better outcomes, …
01/31/2023
Featured
Sleeping Giants: How Employers Can Shape the Future of Health Care
Morgan Health CEO Dan Mendelson joins the Healthy Dialogue podcast …
09/13/2022
ACHP Applauds Senate Passage of Inflation Reduction Act
ACHP applauds the Senate for passing the Inflation Reduction Act, …
08/07/2022
Letter to Congressional Leadership on Ways to Improve Affordability in Health Care
The Alliance of Community Health Plans has sent Congressional Leaders …
04/25/2022
Statement on CMS Ruling for Aduhelm Coverage
ACHP responds to the Biden Administration's announcement of Medicare coverage …
04/07/2022
Biden’s State of the Union Gears Toward Affordability
In his first State of the Union, President Biden recommitted …
03/02/2022
Resource Library Search
Search by
ACHP Letter to CMS on Broker Payment Reform
ACHP sent a letter to CMS encouraging the Administration to include policy recommendations in MA for Tomorrow in the Contract Years 2025 Part C and D Policy and Technical Changes …
09/22/2023
ACHP’s MA for Tomorrow FAQ Sheet
ACHP released a set of Frequently Asked Questions to support MA for Tomorrow, our vision for Medicare Advantage.
09/15/2023
ACHP Letter to CMS on Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems
ACHP sent a comment letter to CMS on the Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs proposed rule.
09/11/2023
ACHP Letter to CMS on Short-Term, Limited-Duration Insurance Plans
ACHP submitted a letter to CMS on the STLDI proposed rule designed to support enhanced consumer experience and greater competition and efficiency in the marketplace.
09/11/2023
ACHP Statement on the Announcement of the First Ten Drugs to be Negotiated in the IRA
As the only national payer organization that supported robust drug pricing reform, including allowing direct government negotiation for drugs without competition, we are pleased by the White House’s announcement of …
08/29/2023
Loading…
